Acute pulmonary hypertension after transjugular intrahepatic portosystemic shunt: a potentially deadly but commonly

Jacqueline Modock1

  • 1Jacqueline Modock, BSN, RN, is Adult Gerontology Acute Care Nurse Practitioner, Lake Tahoe Regional Hospitalist, Carson City, Nevada.

Insights

Transjugular intrahepatic portosystemic shunt (TIPS) can cause acute pulmonary hypertension in patients with Hepatitis C virus (HCV) cirrhosis. This case report highlights this often-missed complication, discussing its incidence, diagnosis, and treatment.

Area of Science:

  • Hepatology
  • Cardiology
  • Transplantation

Background:

  • Hepatitis C virus (HCV) is a leading cause of chronic liver disease and liver transplantation in the US.
  • Complications of chronic liver disease necessitate management strategies like transjugular intrahepatic portosystemic shunt (TIPS) procedures.
  • The increasing prevalence of HCV cirrhosis leads to a rise in TIPS procedures.

Purpose of the Study:

  • To report a case of acute pulmonary hypertension following a TIPS procedure in a patient with HCV cirrhosis.
  • To raise awareness of this potentially serious but often overlooked complication of TIPS.
  • To discuss the incidence, diagnosis, and treatment of TIPS-induced pulmonary hypertension.

Main Methods:

  • Case report presentation of a 52-year-old male with HCV cirrhosis.
  • Review of the clinical presentation, diagnosis, and management of acute pulmonary hypertension post-TIPS.
  • Discussion of existing literature on TIPS-related complications.

Main Results:

  • The patient developed acute pulmonary hypertension after undergoing a TIPS procedure.
  • This case underscores the importance of recognizing and managing this adverse event.
  • The report details the diagnostic pathway and therapeutic interventions for this complication.

Conclusions:

  • Acute pulmonary hypertension is a significant complication of TIPS in patients with HCV cirrhosis.
  • Early diagnosis and appropriate management are crucial for patient outcomes.
  • Further research into the incidence and optimal treatment strategies for this complication is warranted.

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
50
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
906
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
817
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
2.2K